Vaper Expo Showguide 2019 VAPOUROUND-MAGAZINE-MAY-SHOWGUIDE-2019 WEB_compressed - Page 30

A rundown of the latest vape-related stories and research making the news around the world. Better for health & wealth Smokers who switch to vaping will save an average of £346 per year, according to a study; which equates to an annual saving of £1.1 billion for the combined 3.2 million vapers in the UK. The study was commissioned by the UK Vaping Industry Association (UKVIA) ahead of the launch of VApril, a month-long vaping awareness and education campaign. The campaign was spearheaded by TV doctor, Christian Jessen, who has been vocal about the lack of e-cigarette endorsement in the healthcare sector. The UKVIA study was the widest to date that explored the health, financial, and social benefits of vaping. E-cigarettes do not ‘re-normalise’ smoking A study led by Cardiff University has found e-cigarettes do not ‘re-normalise’ smoking. Researchers used data collected from a number of national surveys that logged 13 and 15-year olds’ responses to questions about their smoking habits. The results found that, during the 2010/2011 period when e-cigarette popularity skyrocketed, there was “no significant change” in the pre-existing trend for smoking among this age group. A secondary finding suggests that positive perceptions of smoking cigarettes declined at a faster rate during e-cigarette proliferation, suggesting that the emergence of e-cigarettes do not encourage a favourable view of conventional cigarettes. 30 | VAPER EXPO SHOWGUIDE New ground The US Food and Drug Administration (FDA) has awarded funding to a Colorado university to test the safety of e-cigarettes on a micro- engineered human lung. The University of Colorado Anschutz Medical Campus has received $3.4 million to create a first-of-its-kind multi-cellular 3D living structure of a human lung, which will contain the same cells that naturally line human airways. Research will determine the toxicity and cancer-causing potential of e-cigarettes, providing a better understanding of their impact on human genes, proteins, pathways, and cell/organ function. Wrapped in controversy British motor racing team McLaren has garnered criticism for its choice of sponsorship at this year’s Indy500 racing event. The famed Formula One constructor will have a paint scheme featuring British American Tobacco (BAT) Vuse e-cigarette branding, at the Indianapolis racing event later this month. McLaren signed a multi-year deal with the brand in February, for a partnership that will focus solely on BAT’s ‘reduced risk products.’ The World Health Organisation (WHO) has called on the International Automobile Federation (FIA) to ban tobacco company sponsorships, even for those that don’t intend to promote tobacco products. The FIA’s Formula One event has had a tobacco advertising ban in place for well over a decade, but BAT’s e-cigarette branding has been accepted as it does not advertise tobacco.